ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Hammer Says “Exciting Times” Should Convince President to Increase Budget, Ok Act Renewal

April 26, 1985